APD Air Products & Chemicals, Inc.
Industrial Inorganic Chemicals · NYSE · SEC CIK 2969 · Fiscal year ends 09/30
Financial factors as of 2026-09-30 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.9%
TTM net income YoY234.9%
TTM EPS YoY235.0%
Revenue 3-yr CAGR1.0%
Net income 3-yr CAGR-38.6%
Margins
Gross margin31.6%
Operating margin0.2%
Net margin4.1%
FCF margin3.7%
EBITDA margin11.9%
Returns
ROE3.6%
ROA1.3%
ROIC (approx.)0.2%
Asset turnover0.32x
Leverage & solvency
Liabilities / assets58.4%
Debt / equity0.00x
Current ratio1.07x
Interest coverage0.11x
Cash quality & payout
Operating cash flow / net income8.80x
Accruals ratio-10.1%
Payout ratio301.3%
Capex / revenue32.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-09-30 | FY20252025-09-30 |
|---|---|---|
| Income statement | ||
| Revenue | $12.99B | $12.04B |
| Cost of revenue | $8.89B | $8.26B |
| Gross profit | $4.10B | $3.78B |
| R&D expense | $88.90M | $96.30M |
| SG&A expense | $903.20M | $906.10M |
| Operating income | $23.30M | -$877.00M |
| Interest expense | $220.40M | $214.00M |
| Pretax income | $552.00M | -$440.70M |
| Income tax | $1.60M | -$94.30M |
| Net income | $532.10M | -$394.50M |
| EBITDA | $1.55B | $687.20M |
| EPS (basic) | 2.39 | -1.77 |
| EPS (diluted) | 2.39 | -1.77 |
| Dividends declared per share | 7.22 | 7.14 |
| Weighted avg. shares (diluted) | 222.90M | 222.70M |
| Balance sheet | ||
| Cash & equivalents | $1.33B | $1.86B |
| Short-term investments | — | $0 |
| Receivables | $1.84B | $1.90B |
| Inventory | $741.20M | $776.50M |
| Current assets | $5.02B | $5.83B |
| PP&E, net | $25.31B | $25.34B |
| Goodwill | $948.60M | $963.90M |
| Intangibles | $262.70M | $293.50M |
| Total assets | $41.21B | $41.06B |
| Current liabilities | $4.71B | $4.22B |
| Short-term debt | $77.00M | $34.70M |
| Total liabilities | $24.06B | $23.71B |
| Shareholders' equity | $14.28B | $15.02B |
| Shares outstanding | 222.69M | 222.59M |
| Cash flow statement | ||
| Operating cash flow | $4.68B | $3.26B |
| Capital expenditure | $4.20B | $7.02B |
| Free cash flow | $476.80M | -$3.77B |
| Investing cash flow | -$4.15B | -$7.17B |
| Financing cash flow | -$1.07B | $2.80B |
| Depreciation & amortization | $1.52B | $1.56B |
| Stock-based compensation | $50.40M | $76.40M |
| Dividends paid | $1.60B | $1.58B |
Free plan shows the latest 2 periods; Pro shows all 20 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.